GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artgen Biotech PJSC (MIC:ABIO) » Definitions » Net Margin %

Artgen Biotech PJSC (MIC:ABIO) Net Margin % : 5.13% (As of Jun. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Artgen Biotech PJSC Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Artgen Biotech PJSC's Net Income for the six months ended in Jun. 2023 was ₽32 Mil. Artgen Biotech PJSC's Revenue for the six months ended in Jun. 2023 was ₽621 Mil. Therefore, Artgen Biotech PJSC's net margin for the quarter that ended in Jun. 2023 was 5.13%.

The historical rank and industry rank for Artgen Biotech PJSC's Net Margin % or its related term are showing as below:

MIC:ABIO' s Net Margin % Range Over the Past 10 Years
Min: -28.51   Med: -1.34   Max: 10.12
Current: 4.28


MIC:ABIO's Net Margin % is ranked better than
79.09% of 1028 companies
in the Biotechnology industry
Industry Median: -154.37 vs MIC:ABIO: 4.28

Artgen Biotech PJSC Net Margin % Historical Data

The historical data trend for Artgen Biotech PJSC's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artgen Biotech PJSC Net Margin % Chart

Artgen Biotech PJSC Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.31 10.12 6.72 0.99 4.06

Artgen Biotech PJSC Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.54 -1.29 4.81 3.42 5.13

Competitive Comparison of Artgen Biotech PJSC's Net Margin %

For the Biotechnology subindustry, Artgen Biotech PJSC's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Artgen Biotech PJSC's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Artgen Biotech PJSC's Net Margin % distribution charts can be found below:

* The bar in red indicates where Artgen Biotech PJSC's Net Margin % falls into.



Artgen Biotech PJSC Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Artgen Biotech PJSC's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=46.118/1136.904
=4.06 %

Artgen Biotech PJSC's Net Margin for the quarter that ended in Jun. 2023 is calculated as

Net Margin=Net Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=31.878/621.115
=5.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Artgen Biotech PJSC  (MIC:ABIO) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Artgen Biotech PJSC Net Margin % Related Terms

Thank you for viewing the detailed overview of Artgen Biotech PJSC's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Artgen Biotech PJSC (MIC:ABIO) Business Description

Traded in Other Exchanges
N/A
Address
Prospect of the 60th Anniversary, Moscow, RUS, 117036
Artgen Biotech PJSC formerly Human Stem Cells Institute PJSC is a biotechnology company. It is engaged in the drug discovery, research and development and marketing of proprietary products and services in the field of regenerative medicine, bio-insurance, medical genetics, including reproductive genetics, gene therapy, and biopharmaceutics. The company has developed Neovasculgen, which is a gene therapy drug for the treatment of Peripheral Arterial Disease, including Critical Limb Ischemia and also develops SPRS therapy which entails the use of autologous dermal fibroblasts to repair skin damage due to aging and other structural changes.

Artgen Biotech PJSC (MIC:ABIO) Headlines

From GuruFocus

ARCA biopharma Announces First Quarter 2023 Financial Results

By sperokesalga sperokesalga 04-24-2023

James Flynn Joins ARCA biopharma Board of Directors

By Value_Insider Value_Insider 12-19-2022

ARCA biopharma Announces Third Quarter 2022 Financial Results

By Value_Insider Value_Insider 10-28-2022

Jacob Ma-Weaver Joins ARCA biopharma Board of Directors

By GuruFocusNews GuruFocusNews 06-21-2022

ARCA biopharma Establishes Special Committee of the Board of Directors

By GuruFocusNews GuruFocusNews 04-18-2022